KANFIT LTD

Their core work

Kanfit is an Israeli manufacturing SME that brings hands-on industrial production capability to EU research consortia. Their participation in HYPERDIAMOND — a project developing diamond-based nanoparticle probes for hyperpolarized MR imaging — suggests a role in precision fabrication or advanced materials processing for biomedical applications. Their move into KYKLOS 4.0 reveals a deeper alignment with smart, reconfigurable manufacturing systems, including CPS-enabled production lines and circular economy principles. As a private company in a technology-intensive industrial region of northern Israel, Kanfit appears to serve as a real-world manufacturing testbed and industrial validation partner within research consortia.

What they specialise in

How they've shifted over time

Kanfit's earliest H2020 engagement (2016–2020) was in hyperpolarized medical imaging — a highly specialised health technology domain involving quantum phenomena and diamond nanoparticles — where their likely role was precision manufacturing or materials processing rather than imaging science itself. By 2020, they had pivoted sharply toward industrial digital transformation: circular manufacturing, flexible production, and agent-based B2B manufacturing platforms. This trajectory suggests a company whose core identity is advanced manufacturing, applied first in a high-tech health context and then redirected toward the Industry 4.0 and circular economy space where their manufacturing expertise is the central contribution.

Kanfit is moving decisively toward Industry 4.0 and circular manufacturing, making them a credible industrial partner for future projects involving reconfigurable production, digital factory pilots, or sustainable manufacturing validation in real industrial settings.

How they like to work

Kanfit has never led an H2020 project — they join as a participant in every case, indicating a preference or positioning as a specialist contributor rather than a consortium manager. Their two projects generated 44 unique partners across 16 countries, which means they consistently operate inside large, multi-partner consortia rather than small focused collaborations. This pattern is typical of industrial SMEs who provide real-world testing or production capacity: valuable as a validation site, but not in the driver's seat on research direction.

Despite having only two projects, Kanfit has connected with 44 unique partners across 16 countries — a sign that both consortia were large, pan-European initiatives rather than bilateral collaborations. Their network spans far beyond Israel's usual research partnerships, with no apparent geographic concentration among collaborators.

What sets them apart

Kanfit occupies an unusual niche: an Israeli industrial SME embedded in EU research consortia spanning both health technology and advanced manufacturing — two sectors that rarely share the same partner. Their Israeli base adds a non-EU industrial perspective that consortia sometimes seek for breadth, and their practical manufacturing capability provides something that university labs and research institutes cannot: a real production environment for validation. For consortium builders in manufacturing or medtech, Kanfit offers Israeli industrial access without the complexity of coordinating with a large institution.

Highlights from their portfolio

• HYPERDIAMOND
  A technically ambitious health project combining quantum physics and diamond nanoparticles for MR imaging, where Kanfit's participation as an industrial SME signals a precision fabrication or materials role in an otherwise science-heavy consortium.
• KYKLOS 4.0
  A large Innovation Action focused on circular and agile manufacturing, directly aligned with Kanfit's core industrial identity and the most revealing indicator of their current strategic direction.